Topical versus intravenous tranexamic acid in total knee arthroplasty: A meta-analysis of randomized controlled trials

Journal of Orthopaedic Surgery

Volumn 25, Issue 1, 2017, Pages

  Meena, Sanjay ^a   Benazzo, Francesco ^b   Dwivedi, Saumitra ^c   Ghiara, Matteo ^b  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b UNIVERSITY OF PAVIA   (Italy)

^c ADICHUNCHANAGIRI INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

knee; knee arthroplasty; knee replacement; systematic review; tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

COMPARATIVE STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KNEE REPLACEMENT; META ANALYSIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, TOPICAL; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; HUMANS; TRANEXAMIC ACID;

EID: 85040004856     PISSN: 10225536     EISSN: 23094990     Source Type: Journal    
DOI: 10.1177/2309499016684300     Document Type: Article

References (42)

1. Kurtz S, Ong K, Lau E. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89(4):780–785
2. Prasad N, Padmanabhan V, Mullaji A. Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop 2007; 31(1): 39–44
3. Cushner FD, Friedman RJ. Blood loss in total knee arthroplasty. Clin Orthop Relat Res 1991; 269: 98–101
4. Bower WF, Jin L, Underwood MJ. Peri-operative blood transfusion increases length of hospital stay and number of postoperative complications in non-cardiac surgical patients. Hong Kong Med J 2010; 16(2): 116–120
5. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113(2): 482–495
6. Rajesparan K, Biant LC, Ahmad M. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009; 91(6): 776–783
7. Zohar E, Ellis M, Ifrach N. The postoperative blood-sparing efficacy of oral versus intra-venous tranexamic acid after total knee replacement. Anesth Analg 2004; 99(6): 1679–1683
8. Ortmann E, Besser MW, Klein AA. Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth 2013; 111(4): 549–563
9. Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010; 18(3): 132–138
10. Mongan PD, Brown RS, Thwaites BK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg 1998; 87(2): 258–265
11. Boylan JF, Klinck JR, Sandler AN. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996; 85(5): 1043–1048
12. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003; 63(13): 1417–1433
13. Ipema HJ, Tanzi MG. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother 2012; 46(1): 97–107
14. Gandhi R, Evans HM, Mahomed SR. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184
15. Tan J, Chen H, Liu Q. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 2013; 184(2): 880–887
16. Alshryda S, Sukeik M, Sarda P. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014; 96-B(8): 1005–1015
17. Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop Rev 2011; 3(2): e12
18. Maniar RN, Kumar G, Singhi T. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012; 470(9): 2605–2612
19. Patel JN, Spanyer JM, Smith LS. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014; 29(8): 1080–1083
20. Seo JG, Moon YW, Park SH. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013; 21(8): 1869–1874
21. Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 2014; 96(23): 1937–1944
22. Soni A, Saini R, Gulati A. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty 2014; 29(8): 1525–1527
23. Sarzaeem MM, Razi M, Kazemian G. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J Arthroplasty 2014; 29(8): 1521–1524
24. Aguilera X, Martínez-Zapata MJ, Hinarejos P. Topical and intravenous tranexamic acid reduces hemostasis in total knee arthroplasty: a multicentre randomized controlled trial. Arch Orthop Trauma Surg 2015; 135(7): 1017–1025
25. Digas G, Koutsogiannis I, Meletiadis G. Intra-articular injection of tranexamic acid reduces blood loss in cemented total knee arthroplasty. Eur J Orthop Surg Traumatol 2015; 25(7): 1181–1188
26. Gybel M, Kristensen K, Roseva-Nielsen N. Cardiac arrest caused by massive pulmonary embolism during treatment with tranexamic acid. Ugeskr Laeger 2013; 175(20): 1426–1427
27. Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol 2002; 68(5): 307–309
28. Krivokuca I, Lammers JW. Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid. Clin Appl Thromb Hemost Off J Int Acad Clin Appl Thromb Hemost 2011; 17(1): 106–107
29. Bruce-Brand R, Dragomir R, Baker J. Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration. Acta Orthop Belg 2013; 79(3): 351–354
30. Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–2
31. Tanaka N, Sakahashi H, Sato E. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 2001; 83: 702
32. Sano M, Hakusui H, Kojima C. Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers. Jpn J Clin Pharmacol Ther 1976; 7: 375
33. Benoni G, Bjorkman S, Fredin H. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Investig 1995; 10: 280
34. Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty 2013; 28(7): 1080–1083
35. Ishida K, Tsumura N, Kitagawa A. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011; 35(11): 1639–1045
36. Jang B, Kao M, Bohm MT. Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty. J Orthop Surg (Hong Kong) 2014; 22: 146–149
37. Panteli M, Papakostidis C, Dahabreh Z. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 2013; 20(5): 300–309
38. Wong J, Abrisham iA, El Beheiry H. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92(15): 2503
39. Lin SY, Chen CH, Fu YC. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty 2015; 30(5):776–780
40. Carvalho LH, JrFrois Temponi E, Machado Soares LF. Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study. Orthop Traumatol Surg Res 2015; 101(1): 83–87
41. Gao F, Sun W, Guo W. Topical administration of tranexamic acid plus diluted-epinephrine in primary total knee arthroplasty: a randomized double-blinded controlled trial. J Arthroplasty 2015; 30(8): 1354–1358
42. Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 2014; 21(6): 987–993